Figure 1: Evaluating the prognostic impact of AURKA mRNA expression on any event (AE) and metastatic relapse (MR)-free survival. Kaplan-Meier’s survival curves for breast cancer patients according to tumor expression of AURKA are presented. The p values shown were obtained from a long-rank test among two groups. (A) Association of AURKA expression with AE-free survival. (B) Association of AURKA expression with MR-free survival. (C-F) Effect of AURKA expression levels on AE- and MR-free survival according to ER status. Kaplan- Meier estimates of AE- and MR- free survival according to the AURKA expression levels are shown. The p values were obtained from a long- rank test among two groups.